Fear renewal activates cyclic adenosine monophosphate signaling in the dentate gyrus

• Published in: Brain and behavior 2019-08, Vol.9 (8), p.e01280-n/a
• Main Authors: Shi, Yan-Wei, Fan, Bu-Fang, Xue, Li, Wang, Xiao-Guang, Ou, Xue-Ling
• Format: Article
• Language: English
• Subjects: Adenosine; Animals; Behavior; cAMP; Colforsin - pharmacology; Cyclic AMP - metabolism; dentate gyrus; Dentate Gyrus - drug effects; Dentate Gyrus - metabolism; Experiments; Fear & phobias; Fear - drug effects; Fear - physiology; fear conditioning; fear renewal; Kinases; Laboratory animals; Light; Male; Medical research; Memory - drug effects; Memory - physiology; Neurosciences; Original Research; PDE4; Phosphodiesterase 4 Inhibitors - pharmacology; Proteins; Rats; Rats, Sprague-Dawley; Rolipram - pharmacology; Signal Transduction - drug effects; Signal Transduction - physiology; Stainless steel; Ventilation
• ISSN: 2162-3279; 2162-3279
• DOI: 10.1002/brb3.1280

Background Fear renewal, the context‐specific relapse of a conditioned fear after extinction, is a widely pursued model of post‐traumatic stress disorder and phobias. However, its cellular and molecular mechanisms remain poorly understood. The dentate gyrus (DG) has emerged as a critical locus of plasticity with relevance to memory, anxiety disorders, and depression, and it contributes to fear memory retrieval. Here, we have identified the role of the DG in fear renewal and its molecular mechanism. Materials and Methods Muscimol (MUS), activator of cyclic adenosine monophosphate (cAMP) forskolin (FSK), inhibitor of protein kinase A (PKA), Rip‐cAMP, and a phosphodiesterase inhibitor rolipram were infused into DG of standard deviation rats before renewal testing. cAMP levels after fear renewal was measured by enzyme‐linked immunosorbent assay. The protein levels of phosphodiesterase 4 (PDE4) isoforms were tested by western blot. At last, the roles of cAMP signaling were also tested in the acquisition of fear conditioning, fear retrieval, and extinction. Results Intra‐DG treatment of MUS and Rp‐cAMP impaired fear renewal. FSK and rolipram exhibited the opposite effect, which also occurred in the retrieval of original fear memory. This change in fear renewal was regulated by PDE4 isoforms PDE4A, PDE4A5, and PDE4D. In addition, FSK and rolipram facilitated the acquisition of fear conditioning in long‐term memory, but not short‐term memory, while Rp‐cAMP impaired long‐term memory. For extinction, FSK and rolipram inhibited extinction process, while Rp‐cAMP facilitated fear extinction. Conclusion These findings demonstrated that fear renewal activated cAMP signaling in the DG through decreased PDE4 activity. Because of the role of cAMP signaling in the acquisition or retrieval of fear conditioning and encoding of extinction, it is speculated that initial learning and extinction may have similarities in molecular mechanism, especially fear retrieval and fear renewal may share cAMP signaling pathway in the DG. Blockade or activation of cyclic adenosine monophosphate (cAMP) signaling could disrupt or facilitate fear renewal, respectively. In addition, fear renewal activated cAMP signaling through decreased phosphodiesterase 4 activity.